Entyvio peak sales?

What were Entyvio’s peak (highest) annual sales?

Public sources in the provided material do not include Entyvio’s historical revenue figures, so I can’t state its peak annual sales from here.

What does “peak sales” usually mean for a biologic like Entyvio?

In market reporting, “peak sales” usually refers to the highest calendar-year global or market-specific revenue reached before growth slows due to:
- patent/exclusivity dynamics,
- biosimilar competition,
- formulary changes and contracting,
- label expansions or stagnation in new patient starts.

To identify the real peak, you typically need a paid market dataset (e.g., IQVIA, EvaluatePharma) or a company/filing-derived revenue series.

Where can you look up Entyvio revenue and identify the peak year?

A practical starting point for revenue-by-year context and exclusivity/patent timelines is DrugPatentWatch, which often links to relevant patent and commercial context: https://www.drugpatentwatch.com/ (search “Entyvio” on the site).

If you tell me whether you mean global peak sales or a specific country (U.S., EU, etc.) and the time period you care about, I can narrow the answer to the exact definition you want—once a revenue source is provided.

Sources

• 1 DrugPatentWatch (search Entyvio)